相关实验视频
Updated: May 8, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
预测时间在范围没有低血糖使用一个风险计算器间歇扫描CGM在1型糖尿病
Fernando Sebastian-Valles1, Jose Alfonso Arranz Martin1, Julia Martínez-Alfonso2
1Universidad Autónoma de Madrid, Department of Endocrinology and Nutrition, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.
Endocrinology, diabetes & metabolism
|December 24, 2024
概括
临床和社会经济因素在1型糖尿病中显著影响血糖控制. 在实施间歇扫描连续血糖监测 (isCGM) 后,统计模型可以预测最佳血糖控制 (OGC).
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 生物统计学 生物统计学
背景情况:
- 间歇扫描的持续血糖监测 (isCGM) 系统越来越多地用于1型糖尿病管理.
- 了解影响血糖控制的因素对于优化治疗结果至关重要.
- 社会经济地位可以在健康管理和结果中发挥作用.
研究的目的:
- 为了研究临床和社会经济因素对1型糖尿病患者血糖控制的影响,使用isCGM.
- 开发和验证用于预测最佳血糖控制 (OGC) 后isCGM实施的统计模型.
主要方法:
- 在1072名1型糖尿病患者的回顾性分析中,使用isCGM.
- 收集的临床数据和人口普查部门的净收入.
- 开发了物流回归模型来预测OGC (定义为时间在范围>70%,时间在范围以下<4%),并对其进行内部和外部验证.
主要成果:
- 最有效的预测模型包括年净收入,性别,年龄,糖尿病持续时间,isCGM前的HbA1c,胰岛素剂量/千克,以及性别-HbA1c相互作用.
- 该模型在外部验证队列中实现了72.6%的特异性,67.3%的灵敏性,曲线下的面积 (AUC) 为0.736.
- 通过引导重新抽样进行内部验证,AUC为0.756,整体外部队列有效率为80.4%.
结论:
- 临床和社会经济因素是1型糖尿病中OGC的重要决定因素.
- 统计建模提供了一种可靠的方法来预测使用isCGM系统实现OGC的可能性.
- 这些发现可以为个性化糖尿病管理策略提供信息.
相关概念视频
Hypoglycemia and Glucagon
132
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
132
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
470
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
470
Insulin: Dosing Regimen and Adverse Effects
121
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
121
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203

